Quality Paid Again: SPHQ Beat the Index With Half the Drama

Photo of Omor Ibne Ehsan
By Omor Ibne Ehsan Published

Quick Read

  • SPHQ screens the S&P 500 for return on equity, earnings quality, and low leverage, returning 14% year to date versus the broad index's 8%.

  • Pairing 60% SPY or VOO with a SPHQ sleeve sized between 15% and 20% delivers broad-market beta plus a quality tilt that historically limits drawdowns.

  • When SPY dropped 2.5% in a single week, SPHQ fell less than 1%, illustrating the downside cushion quality stocks provide in late-cycle volatility.

  • Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Quality Paid Again: SPHQ Beat the Index With Half the Drama

© Duncan_Andison / iStock via Getty Images

The quality factor tends to earn its keep when investors start worrying about balance sheets again, and the Invesco S&P 500 Quality ETF (NYSEARCA:SPHQ) is making that case in real time. SPHQ owns roughly 100 names from the S&P 500 that score highest on return on equity, accruals quality, and financial leverage. So far this year, SPHQ is up 15% year to date while the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 9.2%, and the gap has been widening as the broader market wobbles.

What you actually own

The S&P 500 Quality Index screens its parent universe on three measures. Return on equity captures how efficiently a company turns shareholder capital into profit. The accruals ratio flags companies whose reported earnings drift from actual cash flow, catching aggressive bookkeeping. Financial leverage penalizes balance sheets dependent on cheap credit.

The roughly 100 highest scorers get weighted by quality score times market cap. The result tilts heavily toward mature, cash-generative businesses in tech, healthcare, and industrials, away from highly levered utilities, REITs, and speculative growth names.

Does the strategy pay

Over five years, SPHQ has returned 95% against SPY’s 88%. Over ten years SPHQ delivers 302% versus the index’s 314%. Both ETFs have been neck-and-neck as long as you keep reinvesting the dividends. The quality factor works by removing the worst quartile of the S&P 500 from your portfolio, and over long horizons that compounds quietly. Unfortunately, that hasn’t been enough to outperform the SPY yet.

The recent picture matters more for the late-cycle thesis. In the past week, as SPY sold off 2.5%, SPHQ gave up only 0.48%. On Friday’s 3% drop in the broad index, SPHQ fell 2%. Small individual numbers, but they show the pattern.

Where the strategy gives back

The trailing twelve months tell a less flattering story. SPHQ returned 22% while SPY returned 25%. In risk-on rallies led by speculative, unprofitable, or highly levered names, quality lags. You will miss some of tech gains, the junk-bond rallies, and moments when investors reward leverage.

Concentration is the quieter risk. The quality screen funnels capital into a narrower slice of large-cap tech and healthcare than the headline index, so when those sectors hit air pockets, SPHQ lacks utilities or energy ballast to cushion the fall. The expense ratio also runs higher than vanilla S&P 500 trackers, which over decades chips away at the factor premium.

Where SPHQ fits

For a retirement-focused portfolio, SPHQ works well as a defensive complement alongside a broad-market core. A reasonable construction looks like a 60% SPY or Vanguard S&P 500 ETF (NYSEARCA:VOO) position with a 15% to 20% SPHQ sleeve, giving you cheap beta plus a quality tilt that historically lowers drawdowns without forfeiting upside.

Investors who want the same factor in cleaner academic form can look at the iShares MSCI USA Quality Factor ETF (NYSEARCA:QUAL), which uses a similar three-factor screen across a broader US universe. SPHQ’s S&P 500 universe makes it the tighter complement when your core is already an S&P 500 fund.

If you expect a sustained risk-on melt-up driven by speculative names, SPHQ will frustrate you. If you suspect the next 12 to 24 months involve more weeks like the last one, the fund is doing exactly what it was designed to do.

 

Photo of Omor Ibne Ehsan
About the Author Omor Ibne Ehsan →

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.

Continue Reading

Top Gaining Stocks

INTC Vol: 97,803,437
MU Vol: 38,756,270
KLA
KLAC Vol: 612,235
AMAT Vol: 4,551,832
LRCX Vol: 5,295,389

Top Losing Stocks

CTRA Vol: 73,319,495
TEL Vol: 2,164,864
HSY Vol: 1,159,151
REGN Vol: 423,757
VMC Vol: 569,365